Status of breast cancer in Latin American: Results of the breast cancer revealed initiative.

Breast cancer Breast cancer management Breast cancer screening Cancer care Latin America Public health

Journal

Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 08 09 2022
revised: 25 11 2022
accepted: 27 11 2022
pubmed: 4 12 2022
medline: 4 1 2023
entrez: 3 12 2022
Statut: ppublish

Résumé

The Breast Cancer Revealed initiative was designed and conducted to know the status of breast cancer at each point of breast cancer care, through i) prevention, ii) detection, iii) diagnosis, iv) treatment, and iv) the capacity of our health systems. The expert panel from 11 Latin American countries identified several strategies and proposed high impact priorities, including implementation of prevention policies, improve primary healthcare capacity for breast cancer screening, have adequate infrastructure to make effective and timely diagnoses, have a multidisciplinary team in the treatment process, access to a variety of treatments for all types of patients, have a coordinated and articulated system from primary care to specialized hospital. In a region with limited resources, prioritization in high-impact strategies for breast cancer control could lead to improved clinical outcomes and quality of life for our patients.

Identifiants

pubmed: 36462594
pii: S1040-8428(22)00314-6
doi: 10.1016/j.critrevonc.2022.103890
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103890

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest Statement JMC received grants from Roche and Genomic Health and payment for lectures from BRP Oncology Updates and Roche Bolivia. The other authors declare they have not potential conflict of interests with this research.

Auteurs

Natalia Ayala (N)

Servicio de Oncología Clínica, Hospital Dr. Jose Ramon Vidal, Corrientes, Argentina.

Sabrina Barchuk (S)

Sección Patología Mamaria, División Ginecología, Hospital General de Agudos Juan A. Fernández, Buenos Aires, Argentina.

Gloria Inurrigarro (G)

Departamento de Patología, Sanatorio Mater Dei, Buenos Aires, Argentina; Departamento de Patología, Hospital Maria Curie, Buenos Aires, Argentina.

Constanza Celano (C)

Secretaria Académica de la Especialidad en Enfermería Oncológica, Universidad Austral, Buenos Aires, Argentina.

Jorge Luis Soriano-García (JL)

Departamento de Oncología, Hospital Ameijeiras, La Habana, Cuba.

Patricia Bolaños (P)

Departamento de Enfermería, Oncomédica, Ciudad de Guatemala, Guatemala.

Mónica Mohs-Alfaro (M)

Departamento de Patología, Hospital Rafael Ángel Calderón Guardia, Costa Rica.

Hector Tapia-González (H)

Departamento de Radiología, Instituto Oncológico Nacional, Panama.

Ramón Perez-Martinez (R)

Servicio de Tumores Mamarios del Instituto de Oncología Dr. Heriberto Pieter, República Dominicana.

Suraj Samtani (S)

Medical Oncology Department, Clinica Las Condes, Santiago, Chile.

Isabel Alvarado-Cabrero (I)

Departamento de Patología, Centro Médico Nacional Siglo XXI, Ciudad de Mexico, Mexico.

Cynthia Villarreal-Garza (C)

Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico.

Jaime Tamez-Salazar (J)

Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico.

Gerardo I Magallanes-Garza (GI)

Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Servicio de Ginecologia y Obstetricia Tec Salud, Monterrey, México.

Daniela Vazquez (D)

Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico.

Janeth Castro (J)

Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico.

Gabriela S Gómez-Macías (GS)

Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico; Universidad Autonoma de Nuevo Leon, Facultad de Medicina, Monterrey, Mexico.

Ana Ferrigno (A)

Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico.

Zaida Morante (Z)

Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.

Sheila Vilchez (S)

Departamento de Cirugía en Mamas y Tejidos Blandos, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.

José Manuel Cotrina (JM)

Departamento de Cirugía en Mamas y Tejidos Blandos, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.

Franco Doimi (F)

Departamento de Patología, Oncosalud-Auna, Lima, Peru.

Guianeya Santander (G)

Servicio de Oncología, Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay.

Carlos Acevedo (C)

Servicio de Mastología, Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay.

Virginia Ortega (V)

Diagnóstico SRL, Montevideo, Uruguay.

Fernando Lavista (F)

Departamento de Radiología, Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay.

Lucía Richter (L)

Servicio de Oncología Médica, Caja Petrolera Santa Cruz, Santa Cruz de la Sierra, Bolivia.

Mario Gianella (M)

Servicio de Cirugía Oncológica, Caja Petrolera Santa Cruz, Santa Cruz de la Sierra, Bolivia.

Maria Paredes (M)

Servicio de Oncología, Instituto de Previsión Social, Asunción, Paraguay.

Christian H Flores-Balcázar (CH)

Servicio de Radioterapia y Física Médica del Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico.

Joseph A Pinto (JA)

Escuela Profesional de Medicina Humana-Filial Ica, Universidad Privada San Juan Bautista, Ica, Peru. Electronic address: jpinto@gecoperu.org.

Henry L Gomez (HL)

Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru; Instituto de Investigaciones en Ciencias Biomedicas, Universidad Ricardo Palma. Lima-Peru.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH